The superior vestibular nerve was studied histologically in 25 patients who underwent removal of inferior vestibular nerve schwannoma. In most cases, the nerve fibers were structurally normal but the endoneurial space showed various degrees of capillary stasis and/or extravasation of red blood cells. Increased fibrosis of the endoneurial space was seen in about two-thirds of the cases; it was mild in all except two cases. The endoneurial space appeared edematic in about one-third of the cases. Wallerian degeneration of individual fibers was occasionally observed in most cases and was severe in the two cases with moderate or severe endoneurial fibrosis. In about one-third of the cases there were large numbers of myelinated nerve fibers with thinned myelin sheaths. The observed structural changes are compatible with those seen in human and experimentally induced chronic compressive or entrapment neuropathies. Thus, early symptoms of eighth-nerve tumors might develop due to direct compression of the eighth-nerve trunk within the internal auditory canal.

Keywords:
Superior vestibular nerve, Acoustic tumor, Chronic compression, Light and electron microscopy, Caloric tests
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.